5 Simple Techniques For T-1101 tosylate
Dependant on the higher incidence of PE with 2 times-day-to-day dosing of dasatinib, at the time-daily dosing regimen is currently recommended for therapy of CML and ALL [sixteen]. Univariate Examination of association concerning condition period and development of PE unveiled that treatment with dasatinib in accelerated stage and blast crisis can